Mostrar el registro sencillo del ítem

dc.rights.licenseopenen_US
dc.contributor.authorRIVAYA, Belén
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorLE ROY, Chloé
dc.contributor.authorJORDANA-LLUCH, Elena
dc.contributor.authorFERNÁNDEZ-RIVAS, Gema
dc.contributor.authorCASAÑ, Cristina
dc.contributor.authorGONZÁLEZ, Victoria
dc.contributor.authorWANG-WANG, Jun Hao
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorBÉBÉAR, Cécile
dc.contributor.authorMATAS, Lurdes
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorPEREYRE, Sabine
dc.date.accessioned2025-01-14T07:47:42Z
dc.date.available2025-01-14T07:47:42Z
dc.date.issued2022-04-05
dc.identifier.issn2079-6382en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/204248
dc.description.abstractEnMacrolide and fluoroquinolone resistance (MLr/FQr) in (MG) infections is concerning worldwide. Current guidelines recommend performing MLr detection in MG-positive cases to adjust antimicrobial therapy. We aimed to evaluate the usefulness of PCR followed by pyrosequencing for MLr detection in comparison with a one-step commercial assay and to assess the prevalence of MLr and FQr in Badalona, Spain. A total of 415 MG-positive samples by Allplex STI-7 (Seegene) were analyzed for MLr detection by pyrosequencing. From those, 179 samples were further analyzed for MG and MLr by ResistancePlus MG kit (SpeeDx) and 100 of them also for fluoroquinolone resistance (FQr) by sequencing the gene. Regarding MG detection, Allplex and Resistance Plus showed an overall agreement of 87%, but this value rose to 95.4% if we compare them for MLr detection. Prevalence of MLr was 23.1% in Badalona, but this rate increased to 73.7% in the HIV-positive patients cohort. FQr detection showed 3% of resistant strains. Pyrosequencing is a convenient and cheap technique for MLr detection, but one-step tools should be considered in high-throughput laboratories. Despite the fact that MLr remained moderate and FQr was low in our study, simultaneous MG and MLr detection would improve patient's management applying resistance-guided treatment strategies.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enMycoplasma genitalium; Spain; fluoroquinolone; macrolide; resistance
dc.title.enDetection and Prevalence of Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium in Badalona, Spain
dc.title.alternativeAntibiotics (Basel)en_US
dc.typeArticle de revueen_US
dc.identifier.doi10.3390/antibiotics11040485en_US
dc.subject.halSciences du Vivant [q-bio]/Microbiologie et Parasitologieen_US
dc.identifier.pubmed35453236en_US
bordeaux.journalAntibioticsen_US
bordeaux.volume11en_US
bordeaux.hal.laboratoriesMFP (Laboratoire Microbiologie Fondamentale et Pathogénicité) - UMR 5234en_US
bordeaux.issue4en_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.identifierhal-04885150
hal.version1
hal.date.transferred2025-01-14T07:47:45Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Antibiotics&rft.date=2022-04-05&rft.volume=11&rft.issue=4&rft.eissn=2079-6382&rft.issn=2079-6382&rft.au=RIVAYA,%20Bel%C3%A9n&LE%20ROY,%20Chlo%C3%A9&JORDANA-LLUCH,%20Elena&FERN%C3%81NDEZ-RIVAS,%20Gema&CASA%C3%91,%20Cristina&rft.genre=article


Archivos en el ítem

Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem